Research Article
New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study
Table 1
Clinical and metabolic characteristics of the patients with type II DM at coronary care unit.
| Characteristics | Number (%), mean ± SD |
| Age (years) | 57.5 ± 12.02 | Male : female ratio | 60% male, 40% female | Race, white : black ratio | 100 : 0 | Onset of chest pain (hrs) | 4.42 ± 2.69 (1–7) | Positive history for IHD | 70 (82.35) | Hypertension | 69 (81.17) | Hyperlipidemia | 79 (92.94) | Duration of hospitalization | 6 ± 2.27 (4–10) | Troponin I positive | 42 (95.45) | Troponin negative | 2 (4.54) | Types of MI | | Anterior | 39 (45.88) | Anteroseptal | 12 (14.11) | Anterolateral | 13 (15.29) | Posterior | 14 (16.47) | Inferior | 7 (6.81) | Complications | 12 (14.11) | Death | 2 (2.35) | Arrhythmia | 7 (8.23) | Shock | 1 (1.17) | Acute heart failure | 2 (2.35) | Pharmacotherapy | | Antiplatelets | 85 (100) | Anticoagulant | 55 (64.70) | Anti-ischemic | 78 (91.76) | Antidiabetic agents | 85 (100) | Metformin | 62 (72.94) | Others | 23 (27.05) | ACEI | 80 (94.11) | Hypolipidemic agents | 78 (91.76) | Analgesics | 22 (50) | Direct current shock (DC) | 6 (70.58) |
|
|
ACEI: angiotensin converting enzyme inhibitor.
|